OUR HISTORY

Bio-Modeling Systems is founded

by Dr. Iris, M. Gea and Dr. Dine

Participation in 2 French nation-wide projects; profitable ever since

2004

2006

  • Development of the CADI™ analytical platform.

  • Four new models completed (FGF4-driven fibroblast differentiation, hypercholesterolemia, Chronic Fatigue Syndrome, Creutzfeldt Jakob disease) two of which are undergoing independent biological evaluation.

  • Synthons White Biotechnology

  • Bio-Defense and Bio-Security 

Invention of 3 proprietary technologies

TAPE, RipH, AbACCUS

allowing the production of  phage banks capable of targeting any known or yet unknown bacteria

2008

Patent covering new therapeutic strategies and creation of a preclinical evaluation platform in the field of psychiatric disorders.

2010

Pherecydes Pharma S.A. spin-off (anti-bacterial bio-agents) incorporation

- Bio-IT World Best Practices Award from the Cambridge Healthtech Institute

State-of-the-Art of Systems Biology applications in Medicine award; European Commission DG 2010

Computational Biophysics of the Skin book publication

2012

 CEA /BMSystems collaborative research in CNS (Psychiatric and Neurological disorders) led to the co-owned patent WO201029131 with a worldwide exclusive license to Theranexus CEA’s spin-off.

First CADI models (v.0) for Neurodegenerative Diseases

2014

  • Parkinson's Disease

  • Alzheimer's Disease

Psychiatric Diseases & Microbiota

2016

Metabolic Disorders & Child Malnutrition

2018

  • Autism Spectrum Disorders (ASD)

  • Bipolar disorder

  • Schizophrenia

  • Depression

  • ADHD

Indian National Program for child​

  • Stunting

  • Wasting

Therapeutic Protocol for Low-Grade Inflammatory Diseases

2020

  • Chronic Fatigue Syndrome/ ME

  • Gulf War Syndrome

GEMMA H2020 14,2 M€ project on

ASD - Microbota Interactions

© 2020 BMSystems